Clinical Trials Underway for Cancer Drugs Licensed by Georgia State University
ATLANTA — Georgia State University’s Office of Technology Transfer and Commercialization previously licensed a technology invented at Georgia State to SIRPant Immunotherapeutics, Inc., a clinical-stage startup company developing cell-based therapeutics to …